138 related articles for article (PubMed ID: 19205621)
1. Activation of CD47 receptors causes histamine secretion from mast cells.
Sick E; Niederhoffer N; Takeda K; Landry Y; Gies JP
Cell Mol Life Sci; 2009 Apr; 66(7):1271-82. PubMed ID: 19205621
[TBL] [Abstract][Full Text] [Related]
2. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins.
Aridor M; Traub LM; Sagi-Eisenberg R
J Cell Biol; 1990 Sep; 111(3):909-17. PubMed ID: 1697300
[TBL] [Abstract][Full Text] [Related]
3. Activation of betagamma subunits of G(i2) and G(i3) proteins by basic secretagogues induces exocytosis through phospholipase Cbeta and arachidonate release through phospholipase Cgamma in mast cells.
Ferry X; Eichwald V; Daeffler L; Landry Y
J Immunol; 2001 Nov; 167(9):4805-13. PubMed ID: 11673483
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses.
Niederhoffer N; Levy R; Sick E; Andre P; Coupin G; Lombard Y; Gies JP
Int J Immunopathol Pharmacol; 2009; 22(2):473-83. PubMed ID: 19505377
[TBL] [Abstract][Full Text] [Related]
5. Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides.
Krüger PG; Mahata SK; Helle KB
Regul Pept; 2003 Jun; 114(1):29-35. PubMed ID: 12763637
[TBL] [Abstract][Full Text] [Related]
6. Cryptide signaling: Amphiphilic peptide-induced exocytotic mechanisms in mast cells.
Mukai H; Kikuchi M; Fukuhara S; Kiso Y; Munekata E
Biochem Biophys Res Commun; 2008 Oct; 375(1):22-6. PubMed ID: 18657517
[TBL] [Abstract][Full Text] [Related]
7. Activation of rat peritoneal mast cells by substance P and mastoparan.
Mousli M; Bronner C; Bueb JL; Tschirhart E; Gies JP; Landry Y
J Pharmacol Exp Ther; 1989 Jul; 250(1):329-35. PubMed ID: 2473189
[TBL] [Abstract][Full Text] [Related]
8. Neomycin is a potent secretagogue of mast cells that directly activates a GTP-binding protein involved in exocytosis.
Aridor M; Sagi-Eisenberg R
J Cell Biol; 1990 Dec; 111(6 Pt 2):2885-91. PubMed ID: 1702786
[TBL] [Abstract][Full Text] [Related]
9. Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface.
Chahdi A; Mousli M; Landry Y
Eur J Pharmacol; 1998 Jan; 341(2-3):329-35. PubMed ID: 9543256
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C.
Barrocas AM; Cochrane DE; Carraway RE; Feldberg RS
Immunopharmacology; 1999 Feb; 41(2):131-7. PubMed ID: 10102794
[TBL] [Abstract][Full Text] [Related]
11. G-proteins as targets for non-immunological histamine releasers.
Mousli M; Bueb JL; Rouot B; Landry Y; Bronner C
Agents Actions; 1991 May; 33(1-2):81-3. PubMed ID: 1716843
[TBL] [Abstract][Full Text] [Related]
12. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
[TBL] [Abstract][Full Text] [Related]
13. Agmatine: a mastoparan-like activity related to direct activation of heterotrimeric G proteins.
Ferry X; Landry Y
Eur J Pharmacol; 2002 Jan; 435(1):19-26. PubMed ID: 11790374
[TBL] [Abstract][Full Text] [Related]
14. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
Mousli M; Hugli TE; Landry Y; Bronner C
Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides.
Shefler I; Zavaro O; Raz T; Baram D; Sagi-Eisenberg R
Int Arch Allergy Immunol; 2008; 145(2):131-40. PubMed ID: 17848806
[TBL] [Abstract][Full Text] [Related]
16. A mastoparan analog without lytic effects and its stimulatory mechanisms in mast cells.
Mukai H; Kikuchi M; Suzuki Y; Munekata E
Biochem Biophys Res Commun; 2007 Oct; 362(1):51-55. PubMed ID: 17692824
[TBL] [Abstract][Full Text] [Related]
17. Effect of NMDA receptor ligands on mast cell histamine release, a reappraisal.
Daeffler L; Nadra K; Eichwald V; Ohresser S; Landry Y
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):512-8. PubMed ID: 10431764
[TBL] [Abstract][Full Text] [Related]
18. A wasp venom mastoparan-induced polyphosphoinositide breakdown in rat peritoneal mast cells.
Okano Y; Takagi H; Tohmatsu T; Nakashima S; Kuroda Y; Saito K; Nozawa Y
FEBS Lett; 1985 Sep; 188(2):363-6. PubMed ID: 2411602
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of structural requirements of mastoparan for mast cell activation-toward the comprehensive prediction of cryptides acting on mast cells.
Mukai H; Suzuki Y; Kiso Y; Munekata E
Protein Pept Lett; 2008; 15(9):931-7. PubMed ID: 18991769
[TBL] [Abstract][Full Text] [Related]
20. The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins.
Chahdi A; Daeffler L; Bueb JL; Gies JP; Landry Y
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):357-62. PubMed ID: 9606019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
